tiprankstipranks
Trending News
More News >
Mochida Pharmaceutical Co., Ltd. (DE:MFY)
:MFY
Germany Market

Mochida Pharmaceutical Co., Ltd. (MFY) Income Statement

Compare
1 Followers

Mochida Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q1 2025), Mochida Pharmaceutical Co., Ltd.'s total revenue was ¥26.63B, an increase of 4.82% from the same quarter last year. In Q1, Mochida Pharmaceutical Co., Ltd.'s net income was ¥1.89B. See Mochida Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 105.16B¥ 102.89B¥ 103.26B¥ 110.18B¥ 103.00B
Gross Profit
¥ 53.79B¥ 52.07B¥ 55.12B¥ 59.55B¥ 54.79B
Operating Expenses
¥ 45.66B¥ 46.27B¥ 46.61B¥ 45.16B¥ 42.79B
Depreciation and Amortization
¥ 2.94B¥ 2.81B¥ 2.67B¥ 2.69B¥ 2.74B
EBITDA
¥ 11.00B¥ 8.97B¥ 11.71B¥ 17.28B¥ 14.75B
Operating Income
¥ 8.13B¥ 5.80B¥ 8.51B¥ 14.39B¥ 12.00B
Other Income/Expenses
¥ -75.00M¥ 358.00M¥ 537.00M¥ 199.00M¥ -104.00M
Pretax Income
¥ 8.05B¥ 6.16B¥ 9.04B¥ 14.59B¥ 11.90B
Net Income
¥ 5.68B¥ 4.55B¥ 6.65B¥ 10.57B¥ 8.59B
Per Share Metrics
Basic EPS
¥ 160.36¥ 126.79¥ 178.93¥ 277.39¥ 222.27
Diluted EPS
¥ 160.36¥ 126.79¥ 178.93¥ 277.39¥ 222.27
Weighted Average Shares Outstanding
35.45M 35.86M 37.16M 38.10M 38.63M
Weighted Average Shares Outstanding (Diluted)
35.45M 35.86M 37.16M 38.10M 38.63M
Currency in JPY

Mochida Pharmaceutical Co., Ltd. Earnings and Revenue History